About Conference:
We are privileged to welcome all attendees to our world-renowned event, we are extremely proud to announce the "2nd International Conference on Alzheimer's and Parkinson's Diseases" in London, UK on November 20-22, 2023.
Parkinson’s 2023 conference will provide new ideas, convictions, strategies, and tactics in an environment where no other conference will provide an impressive roaster of Keynote speakers, quality attendees, and compelling content. The various thematic sessions will be discussed at this conference, and we welcome you all to attend.
The aim of this Parkinson's 2023 conference is to bring together top researchers and scientists to discuss how to disseminate peer-reviewed information on Parkinson’s and the latest developments in the field to the global network of experts studying the latest research works.
Parkinson's 2023 encourages participants from all top academic institutions and clinical research facilities to share their research on all facets of this quickly expanding subject, meet with top researchers, and display the most recent methods.
Once again, we are grateful for all of your excellent and original research. The calculated and pertinent knowledge that is given will also foster expertly coordinated efforts to support rational scientific advancements. We promise you'd have a fantastic relationship with Parkinson's 2023 and a love for the great city of London.
Why to attend?
With enthusiastic support from the Parkinson’s 2023 organizing committee, affiliations, and excellent presentations from neurologists, we work hard to make the "2nd International Conference on Alzheimer's and Parkinson's Diseases" a huge success. This gathering will feature undeniably excellent opportunities to all the attendees, Renowned lecturers, and cutting-edge technology from all around the world to be keen on discovering more about the advancements in the field of neuroscience and neurology and they are all expected to be present at this event. The participants can find specialized speeches, posters, symposiums, and workshops on the most recent developments in neuroscience and neurological disorders by
1. Presentations by renowned speakers, keynote talks by leading professors and researchers, and opportunities for professional development.
2. Open opportunities for Oral and Poster presentations to all renowned speakers, professors, and young researchers.
3. Attendees can explore innovative systems and global business opportunities.
4. The leading platform for opportunities in network management and international business.
Target audience
1. Directors of Parkinson’s Research
2. Doctors
3. Neurologists and Neurosurgeons
4. Psychiatrists,
5. Research Scholars
6. Student Delegates
7. Holistic Health Physicians
8. Psychologists/Psychotherapists
9. Occupational Therapists
10. Business Delegates
11. Professionals of Neurologists
12. Professionals of Neurosurgeons
13. Chiropractic Professionals
14. Psychologist Therapists
15. Industrial professionals
16. Massage and Movement Disorder Therapists
17. University professors
18. Institutes-Medical school students
Benefits of attending the conference:
1. All the accepted abstracts will be published in the respective Conference International journals
2. Global Recognition of Scholars
3. Facilitate sharing and collaboration between world-class researchers
4. Establishing academic and professional relationships
5. Improves confidence in presenting research on an international platform.
6. Interacting with expertise in their respective departments
7. To Learn New Tips & Tactics in the field
8. For Global Networking and Brand Establishment
9. Exposure to the Upcoming Business Trends
10. Assessing the Research and Communication of Research Discoveries
Opportunities for Conference Attendees
For Researchers & Faculty:
*Speaker Presentations
*Poster Display
*Symposium hosting
*Workshop organizing
For Universities, Associations & Societies:
*Association Partnering
*Collaboration proposals
*Academic Partnering
*Group Participation
For Students & Research Scholars:
*Poster Competition (Winner will get Best Poster Award)
*Young Researcher Forum (YRF Award to the best presenter)
*Student Attendee
*Group Registrations
For Business Delegates:
*Speaker Presentations
*Symposium hosting
*Book Launch event
*Networking opportunities
*Audience participation
For Companies:
*Exhibitor and Vendor Booths
*Sponsorships opportunities
*Product launch
*Workshop organizing
*Scientific Partnering
*Marketing and Networking with clients
Important Deadlines
Make a note of the following beneficial Parkinson’s 2023 deadlines.
Conference Dates: November 20-22, 2023
1. Early Bird Registration Deadline (Phase 1): 20th May 2023
2. Abstract Submission Deadline (Phase 2): 30th May 2023
3. Final Paper Submission Deadline: 30th June 2023
4. Notification of Abstract Acceptance/ Rejection: 24-48 hours
Group Registrations Waivers Available
10% Waiver: 3-5 Members
15% Waiver: 6-10 Members
20% Waiver: 11-15 Members
25% Waiver: 16+Members
Please contact Lucy (Senior Program Manager) via email: parkinsons@longdomglobal.com for further assistance.
Scientific Session Tracks:
Track-1: Parkinson’s Disease
Parkinson's disease is a progressive neurological disorder that affects movement and is caused by the loss of dopamine-producing brain cells. It is a chronic neurodegenerative condition that mostly affects the motor system. Typically, the symptoms develop gradually, and as the condition progresses, non-motor symptoms increase in frequency. Tremor, rigidity, slowness of movement and trouble walking are the most noticeable early signs. In this session, we will discuss the latest research findings and treatment options for Parkinson's disease. Our expert speakers will provide insights into the pathophysiology of the disease and explore potential strategies for improving patient outcomes.
Track-2: Insights and Therapeutics: Parkinson’s disease
Insights into the pathophysiology of Parkinson's disease and new therapeutic strategies will be discussed in this session. Symptoms include tremors, rigidity, and balance problems. Treatment options include medication and surgery. Experts will explore emerging treatments that may improve patient outcomes and quality of life.
Track-3: Alzheimer's disease
Alzheimer's disease is a progressive brain disorder that affects memory, thinking, and behavior. It is the most common cause of dementia, with symptoms worsening over time, and currently has no known cure. This session will focus on current advances in Alzheimer's disease research and management. Experts in the field will share insights into the disease's pathology, early detection, and therapeutic approaches for better patient outcomes.
Track-4: Neuromuscular disorders
Neuromuscular disorders are a group of conditions that affect the nervous system and muscles, resulting in weakness, numbness, and pain. Treatment options vary depending on the underlying cause. In this session, experts will discuss current research and treatment options for neuromuscular disorders. Topics will include advances in genetic testing, emerging therapies for conditions such as muscular dystrophy and myasthenia gravis, and the role of physical therapy in managing symptoms.
Track-5: Neurological disorders
Neurological disorders are diseases or injuries that affect the brain, spinal cord, or nerves. These conditions can lead to a range of symptoms, including muscle weakness, sensory loss, and cognitive impairment. Treatment options depend on the specific disorder and its severity. This session will cover a range of neurological disorders, including neuromuscular disorders, neurodegenerative diseases, and movement disorders. Experts will discuss the latest research findings and treatment options, as well as emerging technologies and therapies for improving patient outcomes.
Track-6: Pediatric Neurology and Epilepsy
Pediatric Neurology and Epilepsy is a specialty that focuses on the diagnosis and management of neurological disorders in children, including epilepsy, cerebral palsy, and developmental delays. Treatment options depend on the specific disorder and may include medication, surgery, and therapy. This session will focus on the latest developments in pediatric neurology and epilepsy research. Experts will discuss new diagnostic tools, treatment options, and emerging therapies for children with neurological disorders.
Track-7: Neurosurgery and Spine
Neurosurgery is a specialty that involves the surgical treatment of conditions affecting the nervous system, including the brain, spinal cord, and nerves. It may be used to diagnose, treat, or manage a variety of neurological disorders. In this session, experts will explore the latest advancements in neurosurgery and spine research. Topics will include minimally invasive techniques, spinal cord stimulation, and surgical treatments for conditions such as herniated discs and spinal tumors.
Track-8: Movement Disorders
Movement disorders are a group of conditions that affect the control and coordination of movement. These disorders can result in tremors, muscle rigidity, and impaired balance and posture. Treatment options vary depending on the underlying cause and severity of symptoms. This session will explore the latest developments in the diagnosis and management of movement disorders. Experts will discuss new treatments for conditions such as Parkinson's disease and essential tremor, as well as advances in deep brain stimulation and other surgical interventions.
Track-9: Dementia and Vascular Dementia
Dementia is a syndrome that affects cognitive functioning, including memory, language, and decision-making abilities. Vascular Dementia is a type of dementia that occurs due to reduced blood flow to the brain. Treatment options focus on symptom management and lifestyle modifications. In this session, experts in the field of Dementia and Vascular dementia will discuss the latest research findings and treatment options. Topics will include early detection, management of symptoms, and lifestyle modifications. New developments in drug therapies will also be explored.
Track-10: Neuroimaging
Neuroimaging is a technique that allows medical professionals to visualize the structure and function of the brain and nervous system. This includes methods such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). Neuroimaging is used to aid in the diagnosis and management of neurological disorders.
Track-11: Neuropharmacology and Neuro Chemistry
Neuropharmacology is the study of how drugs affect the nervous system and its function. This includes the development and use of medications to treat neurological disorders, as well as understanding the mechanisms of drug action in the brain and nervous system. This session will focus on the latest developments in neuropharmacology and neurochemistry research. Experts will discuss the development and use of medications to treat neurological disorders, as well as the role of neurotransmitters and receptors in brain function. New therapeutic approaches will be explored.
Track-12: Neuroepigenetics
Neuroepigenetics is the study of how epigenetic modifications, which are changes in gene expression that do not involve alterations to the DNA sequence, can affect the development and function of the nervous system. Understanding the role of epigenetics in neurological disorders may lead to new therapeutic approaches.
Track-13: Cognitive Neuroscience and Psychology
Cognitive Neuroscience and Psychology are interdisciplinary fields that study the neural mechanisms underlying cognitive processes such as perception, attention, memory, and decision-making, as well as their behavioral and psychological correlates. This session will explore the intersection of cognitive neuroscience and psychology research. Experts will discuss the latest findings on brain function, behavior, and cognition, and their implications for mental health and well-being.
Track-14: Neuroscience and computational Neuroscience
Neuroscience is a field of study that focuses on the structure and function of the nervous system, including the brain, spinal cord, and nerves. It encompasses a wide range of disciplines, including biology, psychology, and computer science (AI). This session will focus on the latest research in neuroscience and computational neuroscience. Experts will discuss the use of mathematical models to understand the brain and neurological disorders.
Track-15: Geriatric psychiatry and Neurology
Geriatric psychiatry and Neurology is a field of medicine that focuses on the diagnosis and management of neurological and psychiatric disorders in older adults. Treatment options may include medication, therapy, and lifestyle modifications. Experts will discuss the latest findings on brain function, behavior, and cognition, and their implications for mental health and well-being.
Track-16: Brain Stimulation and Imaging
Brain stimulation and imaging involve using non-invasive techniques to study the brain and treat neurological disorders. Techniques include magnetic resonance imaging (MRI), electroencephalography (EEG), and transcranial magnetic stimulation (TMS). The Brain Stimulation and Imaging session will cover the latest advancements in non-invasive brain stimulation techniques and neuroimaging methods. Experts will discuss their applications in diagnosis, treatment, and research.
Track-17: Neurobiology and Behavior Neuroscience
Neurobiology and Behavior Neuroscience explores the complex relationship between the brain and behavior. This field uses interdisciplinary approaches to study the biological basis of behavior, from genetics to cognition. The Neurobiology and Behavior sessions will explore the fundamental principles underlying brain function and behavior. Topics will include neural circuits, synaptic plasticity, and the molecular basis of behavior. Experts will discuss their implications for disease and therapy.
Track-18: Mitochondrial dysfunction
Mitochondrial dysfunction occurs when mitochondria fail to function properly. It can lead to a range of disorders, including neurodegenerative diseases, cancer, and metabolic disorders. The Mitochondrial Dysfunction sessions will cover the latest research on the role of mitochondria in neurodegenerative diseases, such as Parkinson's and Alzheimer's. Experts will discuss the molecular mechanisms underlying mitochondrial dysfunction and potential therapeutic targets.
Track-19: Brain Disorders and Brain Injury
The Brain Disorders and Brain Injury sessions will focus on the latest research on traumatic brain injury, stroke, and other brain disorders. Experts will discuss the underlying mechanisms, diagnosis, and potential therapeutic strategies. The Brain Disorders and Brain Injury sessions will cover the latest research on the diagnosis and treatment of brain disorders, such as traumatic brain injury and stroke. Experts will discuss their implications for patient care and rehabilitation.
Track- 20: Neurodegenerative diseases
Neurodegenerative diseases are a group of disorders that result in the progressive degeneration of neurons in the brain and nervous system. These conditions can lead to a range of symptoms, including movement disorders, cognitive impairment, and memory loss. Treatment options are limited and focus on symptom management. These sessions will cover a wide range of topics, including the pathology, etiology, diagnosis, treatment, and prevention of various neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and ALS.
Track- 21: Mental Health
Mental health refers to a person's overall psychological well-being, including emotional, social, and cognitive functioning. It can be affected by a variety of factors such as genetics, environment, and life experiences, and may be influenced by mental health conditions such as anxiety, depression, and bipolar disorder. Mental health scientific sessions bring together experts in the field to discuss the latest research and treatment methods for mental health conditions. They provide a forum for knowledge sharing and collaboration.
Track- 22: Psychiatry and Psychiatric Disorders
Psychiatry is a medical specialty that focuses on the diagnosis, treatment, and prevention of mental health disorders. It encompasses a range of approaches, including medication, therapy, and lifestyle changes, to help people achieve optimal mental health. Psychiatry scientific session conferences bring together experts in the field to present and discuss the latest research, clinical practices, and treatments related to mental health. They provide a platform for education, networking, and knowledge exchange.
Market Analysis:
Parkinson's disease is a neurodegenerative disorder that affects millions of people worldwide. As the population ages, the number of people with Parkinson's disease is expected to rise, leading to an increased demand for treatments and therapies to manage the symptoms of the disease. This has led to a growing market for Parkinson's disease research and development.
According to market research, the global Parkinson's disease therapeutics market size was valued at $3.7 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. The market is being driven by the increasing prevalence of Parkinson's disease, advancements in technology, and the development of new treatments.
The report identifies several key players in the Parkinson's disease therapeutics market, including AbbVie, Inc., GlaxoSmithKline, Pfizer, Inc., and Teva Pharmaceuticals. These companies are investing heavily in the research and development of new treatments for Parkinson's disease, such as gene therapies, stem cell therapies, and novel drug delivery systems.
Another important area of research in Parkinson's disease is the development of biomarkers for early detection and diagnosis. Biomarkers can provide valuable insights into the underlying mechanisms of Parkinson's disease and help to identify patients who are at risk of developing the disease before symptoms appear. This can lead to earlier diagnosis and more effective treatments.
The market for Parkinson's disease research is also being driven by the increasing use of technology and artificial intelligence in drug discovery and development. This includes the use of machine learning algorithms to analyze large datasets and identify potential drug targets, as well as the development of wearable devices and mobile applications for tracking symptoms and monitoring treatment outcomes.
Overall, the market for Parkinson's disease research is expected to continue to grow in the coming years as the demand for new treatments and therapies increases. Advances in technology, biomarker development, and artificial intelligence are likely to play an important role in driving innovation in this field, leading to improved outcomes for patients with Parkinson's disease.